Journal article
Clinical and Public Health Implications of Macrolide-Resistant Streptococcus pneumoniae
Journal of Chemotherapy: Protekt Against Respiratory Infection: Dynamic Surveillance of Local Resistance on a Global Scale, Vol.14(sup3), pp.42-56
07/01/2002
DOI: 10.1080/1120009X.2002.11782351
PMID: 12418560
Abstract
Macrolide resistance among Streptococcus pneumoniae is a growing global concern, although its specific impact on public health is not currently well defined. A Consensus Working Group was convened in March 2001 to address whether credible, scientific data substantiate macrolide resistance in S. pneumoniae as: (i) producing significant morbidity; (ii) creating attendant health and economic burdens; (iii) constituting a public health threat; and (iv) warranting intervention, including development of new antibiotics with efficacy against these strains. Despite the limitations of available clinical data, concern about the possibility of treatment failure with macrolides is being expressed in clinical practice and in formal treatment guidelines, threatening the important role of these agents in the treatment of respiratory tract infections. Further studies are required to monitor and control macrolide resistance and evaluate settings in which macrolide treatment failures are occurring, and new therapeutic interventions are needed.
Details
- Title: Subtitle
- Clinical and Public Health Implications of Macrolide-Resistant Streptococcus pneumoniae
- Creators
- R.C Moellering - Beth Israel Deaconess Medical CenterWilliam Craig - William S Middleton Memorial Veterans HospitalMichael Edmond - Medical College of Virginia Campus of Virginia Commonwealth UniversityDavid J FarrellMary Jane Ferraro - Massachusetts General HospitalThomas M File - Summa Health SystemJerome Klein - Boston Medical CenterJohn Lonks - Miriam HospitalJoshua P Metlay - VA Medical Center and University of PennsylvaniaDaniel Sahm - Focus/MRL, IncGeorge H Talbot - Talbot Advisors LLCConsensus Working Grp
- Resource Type
- Journal article
- Publication Details
- Journal of Chemotherapy: Protekt Against Respiratory Infection: Dynamic Surveillance of Local Resistance on a Global Scale, Vol.14(sup3), pp.42-56
- Publisher
- Taylor & Francis
- DOI
- 10.1080/1120009X.2002.11782351
- PMID
- 12418560
- ISSN
- 1120-009X
- eISSN
- 1973-9478
- Language
- English
- Date published
- 07/01/2002
- Academic Unit
- Infectious Diseases; Internal Medicine
- Record Identifier
- 9983905524002771
Metrics
23 Record Views